Supplements Companies Are Cashing In on the Ozempic Wave
With demand for GLP-1 drugs sky-high, the supplement industry is elbowing into the market. Some products are meant to complement meds like Ozempic. Others are positioned as “natural” alternatives.
https://www.wired.com/story/the-ozempic-adjacent-supplement-gold-rush-is-just-getting-started/
Wired (RSS Feed) /
npub124…j4fkd
2024-08-14 11:15:00
Author Public Key
npub124472lz2489wn3yn8jjunp52hyxaeqnwqazq393dgnxlscgmlqlspj4fkdPublished at
2024-08-14 11:15:00Event JSON
{
"id": "85818e61938f7f81cdb2a4bfcd4ab741820bdac587d034147c3e0db8195c23cd",
"pubkey": "556be57c4aa9cae9c4933ca5c9868ab90ddc826e074408962d44cdf8611bf83f",
"created_at": 1723634100,
"kind": 1,
"tags": [
[
"t",
"Science"
],
[
"t",
"Science / Health"
],
[
"t",
"Trust Your Gut?"
],
[
"proxy",
"https://www.wired.com/feed/rss#https%3A%2F%2Fwww.wired.com%2Fstory%2Fthe-ozempic-adjacent-supplement-gold-rush-is-just-getting-started%2F",
"rss"
]
],
"content": "Supplements Companies Are Cashing In on the Ozempic Wave\n\nWith demand for GLP-1 drugs sky-high, the supplement industry is elbowing into the market. Some products are meant to complement meds like Ozempic. Others are positioned as “natural” alternatives.\n\nhttps://www.wired.com/story/the-ozempic-adjacent-supplement-gold-rush-is-just-getting-started/",
"sig": "11d2a49a29f64bf712bab9936fb6c9a167b172fa424ddf29adc40461941d1f561acd2ba7bb6927777f02d0d8bc8d2df029bc034180822f8d35af9d7651d214b3"
}